期刊文献+

bcl-2反义寡核苷酸对小细胞肺癌NCI—H69细胞凋亡的影响 被引量:3

bcl-2 antisense oligodexynucleotides enhances apoptosis in small-cell lung cancer cell line NCI-H69
原文传递
导出
摘要 目的探讨bcl-2反义寡核苷酸能否增加小细胞肺癌细胞NCI—H69的凋亡。方法将NCI—H69细胞培养传代,细胞共分4组,反义寡核苷酸组、正义寡核苷酸组、无义寡核苷酸组和空白对照组,通过脂质体将不同浓度的寡核苷酸导人细胞中,WesternBlot法检测bcl-2蛋白的表达,流式细胞术检测细胞的凋亡率。结果与空白对照组比较,反义寡核苷酸组的bcl-2蛋白表达明显受到抑制,而正义寡核苷酸组和无义寡核苷酸组细胞的bcl-2蛋白表达则与空白对照组差异不明显。反义寡核苷酸组细胞在10、20、40umol/L 3个不同浓度时的凋亡率分别是(9.97±1.54)%、(15.28±1.73)%、(21.41±1.85)%,明显高于空白组和正义链、无义链组阴性对照组,且差异有统计学意义(F=7.19~15.48,q=5.21—7.98,P〈0.01),而转染正义链和无义链组与空白组比较则差异无统计学意义。结论bcl-2反义寡核苷酸能有效封闭bcl-2基因的表达,增加小细胞肺癌细胞的凋亡。 Objective To study the effect of bcl-2 antisense oligodexynucleotides on the apoptosis in human small-cell lung cancer cell line NCI-H69. Methods Cultured cells were divided into 4 groups: antisense oligodexynucleotides(ASODN), sense oligodexynucleotides (SODN), nonsense oligodexynucleotides (NSODN) and control. The different bcl-2 oligodexynucleotides was tmnsfected into corresponding cells using oligofectamine. The expression of bcl-2 was examined by Western blot. The apoptosis rates were measured by flow cytometry (FCM). Results The bcl-2 expression in ASODN group was significantly inhibited compared to the control group, SODN and NSODN groups, but it was not obviously inhibited in SODN and NSODN groups. The apoptosis rate of ASODN group in different concentration was (9.97±1.54) %, (15.28±1.73) % and (21.41±1.85) % respectively, it was significantly higher than that of the control group (F = 7.19-15.48, q = 5.21-7.98, P 〈0.01). Conclusion The bcl-2 ASODN could enhance cell apoptosis rate in small-cell lung cancer by blocking bcl-2 gene effectively.
出处 《肿瘤研究与临床》 CAS 2011年第8期515-517,共3页 Cancer Research and Clinic
关键词 基因 bcl-2 小细胞 寡核苷酸类 反义 凋亡 Genes/bcl-2 Carcinoma, small cell Antisense oligodexynucleotides Apoptosis
  • 相关文献

参考文献11

  • 1Shivapurkar N,Reddy J,Chaudhary PM,et al.Apoptosis and lung cancer:a review.J Cell Biochem,2003,88:885-898.
  • 2Paik KH,Park YH,Ryoo BY,et al.Prognostic value of immunohistochemical staining of p53,bcl-2,and Ki-67 in small cell lung cancer.J Korean Med Sci,2006,21:35-39.
  • 3Tsujimoto Y,Gorham J,Cossman J,et al.The t (14;18)chromosome transloeations involved in B-cell neoplasms result from mistakes in VDJ joining.Science,1985,229:1390-1393.
  • 4贾秀红,谢绍华,李建厂,韩兆东,刘媛媛.Livin反义寡核苷酸对K562细胞增殖和凋亡的影响[J].肿瘤研究与临床,2011,23(1):34-37. 被引量:3
  • 5Tamm I,Dorken B,Hartmann G.Antisense therapy in oncology:New hope for an old idea? Lancet,2001,358:489-497.
  • 6雷小勇,张洹,林剑.一个新的靶点的反义bcl-2寡核苷酸诱导HL-60细胞凋亡的研究[J].暨南大学学报(自然科学与医学版),2001,22(1):125-128. 被引量:6
  • 7Hann CL,Daniel VC,Sugar EA,et al.Therapeutic efficacy of ABT737,a selective inhibitor of BCL-2 in small cell lung cancer.Cancer Res,2008,68:2321-2328.
  • 8Rudin CM,Otterson GA,Mauer AM,et al.A pilot trial of G3139,a bcl-2 antisense oligonucleotide,and paclitaxel in patients with chemorefractory small-cell lung cancer.Ann Oncol,2002,13:539-545.
  • 9Rudin CM,Kozloff M,Hoffman PC,et al.Phase I study of G3139,a bcl-2 antisense oligonucleotide,combined with carboplatin and etoposide in patients with small cell lung cancer.J Clin Oncol,2004,22:1110-1117.
  • 10Rudin CM,Salgia R,Wang X,et al.Randomized phase Ⅱ study of carboplatin and etoposide with or without the bcl-2 antisense oligonucleotide oblimersen for extensive-stage small-cell lung cancer:CALGB30103.J ClAin Oncol,2008,26:870-876.

二级参考文献12

  • 1Lin JH,Deng G,Huang Q,et al.KIAP,a novel member of the inhibitor of apoptosis protein family.Biochem Biophys Res Connntm,2000,279:820-831.
  • 2Liu B,Han M,Wen JK.Livin/ML-IAP as a new target for cancer treatment.Cancer Letters,2007,250:168-176.
  • 3Ashhab Y,Alian A,Polliack A,et al.Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern.FEBS Lett,2001,20,495:56-60.
  • 4Lacass EC,Baird S,Komeluk RG,et al.The inhibitors of apoptosis (IAPs) and their emerging role in cancer.Oncogene,1998,17:3247-3259.
  • 5Yagihashi A,Asanuma K,Kobayashi D,et al.Detection of autoantibodies to Livin and survivin in Sera from lung cancer patients.Lung Cancer,2005,48:217-221.
  • 6Xiang YQ,Yao HR,Wang SS,et al.Prognostic value of Survivin and Livin in nasopharyngeal carcinoma.Laryngoscope,2006,116:126-130.
  • 7Kasof GM,Gomes BC.Livin,a novel inhibltor of apoptosis protein family member.Biol Chem,2001,276:3238-3246.
  • 8Ka H,Hunt JS.Temporal and spatial patterns of expression of inhibitor of apoptosis in human placentas.AmJ Pathol,2003,163:413-422.
  • 9Nachmias B,Ashhab Y,Bucholtz V,et al.Casepase-mediated cleavage converts livin from an antiapoptotic to a proapoptotic factor:implications for drug-resistant melanoma.Cancer Res,2003,63:6340-6349.
  • 10Keith F J,Leukemia,1995年,9卷,131页

共引文献7

同被引文献31

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部